Laboratory Corp of America Holdi (NYSE: LH) has reported E.P.S. of $2.71 for its first fiscal quarter (ending March 31) versus $2.35 for the same period a year ago. E.P.S. were $4.61 for the latest four quarters through March 31 versus $8.74 for the same period a year ago.
Recent Price Action
On 4/25/24, Laboratory Corp of America Holdi (NYSE: LH) stock declined by -4.6%, closing at $198.35. Moreover, exceptionally high trading volume at 259% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -0.8% during the last week.
Current PriceTarget Research Rating
LH is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Laboratory has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Laboratory has a slightly negative Appreciation Score of 30 and a neutral Power Rating of 50, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment